This study demonstrated that lncRNA A2M-AS1 reduces oxidative stress and improves Parkinson's disease by regulating TP53INP1-mediated mitophagy through interaction with IGF2BP1 by combining molecular results and results of clinical samples and animal experiments both in vivo and in vitro. This evidence concerns the gene TP53INP1 and Parkinson disease.